-+undefined NaN%
-+undefined NaN%
-+undefined NaN%

U.S. FDA approves Eisai, Biogen's Alzheimer's drug

Reuters · 01/06/2023 14:10
U.S. FDA approves Eisai, Biogen's Alzheimer's drug

- The U.S. Food and Drug Administration approved Eisai Co Ltd's 4523.T and Biogen Inc's BIIB.O Alzheimer's drug lecanemab for patients in the earliest stages of the mind-wasting disease, the agency said on Friday.


(Reporting by Deena Beasley in Los Angeles and Bhanvi Satija in Bengaluru; Editing by Bill Berkrot)

((deena.beasley@thomsonreuters.com; 213 955 6746;))